Results 11 to 20 of about 2,520 (189)
Pediatric Neurology Briefs, 1990 Three infants with a relapsing form of infant botulism are reported from the Division of Child Neurology, The Children’s Hospital of Philadelphia, PA.
J Gordon Millichap
doaj +2 more sources
Infant Botulism and Carbohydrate Blood Group Antigens: Preliminary Results from a Discordant Twin Study [PDF]
Journal of Pediatrics: Clinical PracticeObjective: We investigated if specific carbohydrate blood group antigens were associated with infant botulism (IB) among discordant twins and triplets.
Haydee A. Dabritz, PhD +6 more
doaj +2 more sources
Infant Botulism in the Very Young Neonate: A Case Series [PDF]
American Journal of Perinatology Reports, 2017 Background Though botulism is a rare disease overall, all infants younger than 1 year of age are at risk of contracting infant botulism, the most prevalent form reported in the United States.
Laura Jackson +4 more
doaj +2 more sources
Genomic Characterization of Strains From a Cluster of Infant Botulism Type A in a Small Town in Colorado, United States [PDF]
Frontiers in Microbiology, 2021 Three cases of infant botulism were reported in a small Colorado town between 1981 and 1984. The first two cases occurred in 1981, 6 months apart, and the third case occurred in 1984. Clostridium botulinum type A was isolated from stool of all three case
Lori Gladney +2 more
doaj +2 more sources
Infant Botulism, Israel, 2007–2021 [PDF]
Emerging Infectious Diseases, 2023 Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking.
Bar Goldberg +12 more
doaj +2 more sources
EDIS, 2009 Revised! ENY128, a 2-page fact sheet by Malcolm T. Sanford, Eddie Atkinson, and Jamie Ellis, prepares beekeepers to answer questions responsibly about honey as a potential source of C. botulinum spores, which can cause botulism in infants under 12 months
Malcolm T. Sanford +2 more
doaj +8 more sources
Zdravniški Vestnik, 2013 Infant botulism is a potentially fatal disease, caused by neurotoxigenic strain of Clostridium botulinum that colonizes infant’s gut. The incidence of the disease is low, but is probably underestimated in Europe.
Anja Radšel +4 more
doaj +2 more sources
Infant botulism: an underestimated problem. A review [PDF]
Терапевтический архивThe article is devoted to a form of botulism that has been little studied in our country and is registered exclusively in infants. The fundamental difference between this form and the most common foodborne botulism is that infants become infected by ...
Valeri A. Malov +3 more
doaj +2 more sources
When BAT Precedes BIG‐IV in Infant Botulism: The Need for Structured Antitoxin Decision‐Pathway Reporting in Case Reports [PDF]
Clinical Case ReportsIn infant botulism, use of equine‐derived botulinum antitoxin before BIG‐IV may be clinically justified when the infant‐specific product is delayed.
Muhammad Abdullah Awan +1 more
doaj +2 more sources
Trial of Immune Globulin in Infant Botulism
Pediatric Neurology Briefs, 2006 A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by ...
J Gordon Millichap
doaj +2 more sources